Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TORO 1: Enfuvirtide + Optimized Background in Experienced HIV
NCT00008528Phase 3Completed
- Sponsor
- Roche
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of enfuvirtide in human immunodeficiency virus infection (HIV), sponsored by Roche. Status: completed.
02
Drugs
enfuvirtide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00008528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00008528.